Simcere Pharmaceutical Group Ltd (2096.HK)
Company Info
| ISIN | HK0000658531 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
Highlights
| Market Cap | HK$13.99B |
|---|---|
| PE Ratio | 18.31 |
| Revenue (TTM) | HK$7.00B |
| Gross Profit (TTM) | HK$3.92B |
| EBITDA (TTM) | HK$799.97M |
| Year Range | HK$4.94 - HK$10.18 |
| Target Price | HK$9.68 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Simcere Pharmaceutical Group Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Simcere Pharmaceutical Group Ltd had a return of -23.92% year-to-date (YTD) and -45.82% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -23.92% | 5.90% |
| 1 month | -3.21% | -1.28% |
| 6 months | -22.31% | 15.51% |
| 1 year | -45.82% | 21.68% |
| 5 years (annualized) | N/A | 11.74% |
| 10 years (annualized) | N/A | 10.50% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -22.73% | 7.12% | -4.67% | |||||||||
| 2023 | 4.75% | 6.56% | 8.21% | -8.81% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Simcere Pharmaceutical Group Ltd(2096.HK)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Simcere Pharmaceutical Group Ltd (2096.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Simcere Pharmaceutical Group Ltd granted a 3.43% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.18 per share.
| Period | TTM | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Dividend | HK$0.18 | HK$0.18 | HK$0.18 | HK$0.18 |
Dividend yield | 3.43% | 2.61% | 1.51% | 2.01% |
Monthly Dividends
The table displays the monthly dividend distributions for Simcere Pharmaceutical Group Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||||
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.18 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.18 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2021 | HK$0.18 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Simcere Pharmaceutical Group Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Simcere Pharmaceutical Group Ltd was 62.49%, occurring on Feb 5, 2024. The portfolio has not yet recovered.
The current Simcere Pharmaceutical Group Ltd drawdown is 61.82%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -62.49% | Jul 2, 2021 | 640 | Feb 5, 2024 | — | — | — |
| -33.13% | Oct 30, 2020 | 131 | May 11, 2021 | 19 | Jun 8, 2021 | 150 |
| -6.79% | Jun 16, 2021 | 1 | Jun 16, 2021 | 8 | Jun 28, 2021 | 9 |
| -1.34% | Jun 29, 2021 | 1 | Jun 29, 2021 | 1 | Jun 30, 2021 | 2 |
Volatility
Volatility Chart
The current Simcere Pharmaceutical Group Ltd volatility is 6.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |